Granules India's management had also highlighted on the earnings call that they are expecting revenues to not decline anymore and that the new launches will help the growth in sales. Shares of ...

Research untangles role of stress granules in neurodegenerative disease Date: May 28, 2025 Source: St. Jude Children's Research Hospital Summary: Scientists found that stabilizing stress granules ...

Mutations that stabilize stress granules reversed the effects of disease-causing mutations in test tubes and cells, pointing to a protective role of stress granules in neurodegenerative diseases.

Granules India, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹502.45. The stock has experienced fluctuations today, with a ...

Granules India has completed its acquisition of Senn Chemicals AG, a Switzerland-based contract development and manufacturing organisation (CDMO), for 20 million Swiss franc (CHF) (approximately Rs ...

Granules India has successfully closed previously announced acquisition of Senn Chemicals AG, a Swiss-based Contract Development and Manufacturing Organisation (CDMO), specialising in peptide ...

Shares of Granules India Ltd. fell as much as 3% on Wednesday, March 5, after the United States Food and Drug Administration (USFDA) made the warning letter issued to the company's Gagillapur unit ...

Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in a newly published rebuke by the U.S. FDA. In a warning letter dated ...

Granules India's shares fell nearly 8% after the US FDA issued a warning letter regarding its Gagillapur facility, citing four concerns. The company confirmed progress in addressing these issues ...

Granules India shares slipped 7.07 per cent in Friday's trade on BSE, logging an intraday low at Rs 471.8 per share. The stock was under pressure after the United States food and drugs administration ...

The USFDA issued a warning letter to Granules India Ltd's Gagillapur facility after an August 2024 inspection highlighted compliance issues. While existing operations continue, pending product ...

Granules India Limited has acquired Senn Chemicals AG, a Swiss-based contract development and manufacturing organisation (CDMO) specialising in peptides, for Rs 192 crore.. The closing of the ...